Trump order on drug pricing seems to subject refined risk to pharma


Thank you for reading this post, don't forget to subscribe!

File this below “Decrease your value — or else!”

Tucked contained in the government order on drug pricing from President Trump is a sentence that seems to threaten pharmaceutical corporations that their medicines could also be withdrawn if they don’t decrease costs.

Particularly, the order issued on Monday accommodates a provision regarding “most-favored nation” pricing, which might require pharmaceutical corporations to cost Individuals costs for medicines which can be akin to what individuals pay in international locations which can be just like the U.S.

STAT+ Unique Story

STAT+





This text is unique to STAT+ subscribers

Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.

Have already got an account? Log in

View All Plans

To learn the remainder of this story subscribe to STAT+.

Subscribe